Pierre Heimendinger
Corporate Officer/Principal presso TXCELL
Profilo
Pierre Heimendinger is currently the Vice President-Process Development at Sangamo Therapeutics France SAS.
He holds a doctorate degree from Université Paris Diderot-Paris 7.
Posizioni attive di Pierre Heimendinger
| Società | Posizione | Inizio |
|---|---|---|
| TXCELL | Corporate Officer/Principal | - |
Formazione di Pierre Heimendinger
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Sangamo Therapeutics France SAS
 Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
| Université Paris Diderot-Paris 7 | Consumer Services |
- Borsa valori
- Insiders
- Pierre Heimendinger
